Martha Jokisch
Overview
Explore the profile of Martha Jokisch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
188
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schramm S, Rinck C, Krizanovic N, Jockel K, Husing A, Gronewold J, et al.
Alzheimers Dement (Amst)
. 2025 Jan;
17(1):e70061.
PMID: 39822293
Introduction: The aim of the study was to estimate the population-based dementia incidence in Germany over a period of two decades. Methods: We analyzed data from 4814 participants of the...
2.
Krizanovic N, Jokisch M, Jockel K, Schmidt B, Stang A, Schramm S
J Alzheimers Dis
. 2024 Jul;
100(2):495-507.
PMID: 38995781
Background: There are indications for sex-specific differences regarding the association between kallikrein-8 (KLK8) and cognitive impairment in early stages of Alzheimer's disease for which KLK8 may be an early blood-based...
3.
Mayer G, Frohnhofen H, Jokisch M, Hermann D, Gronewold J
Front Neurosci
. 2024 Apr;
18:1372326.
PMID: 38586191
Due to worldwide demographic change, the number of older persons in the population is increasing. Aging is accompanied by changes of sleep structure, deposition of beta-amyloid (Aß) and tau proteins...
4.
Ogurtsova K, Soppa V, Weimar C, Jockel K, Jokisch M, Hoffmann B
Environ Pollut
. 2023 May;
331(Pt 1):121898.
PMID: 37244536
Little is known about the impact of long-term ambient air pollution (AP) and noise exposure on change in cognitive function over years in the elderly. In this study, we wanted...
5.
Schramm S, Krizanovic N, Roggenbuck U, Jockel K, Herring A, Keyvani K, et al.
J Alzheimers Dis Rep
. 2023 May;
7(1):327-337.
PMID: 37220622
Background: Blood kallikrein-8 is supposed to be a biomarker for mild cognitive impairment (MCI) due to Alzheimer's disease (AD), a precursor of AD dementia. Little is known about the association...
6.
Gronewold J, Jokisch M, Schramm S, Himpfen H, Ginster T, Tenhagen I, et al.
Eur J Neurol
. 2023 Jan;
30(5):1174-1190.
PMID: 36702775
Background: White matter hyperintensities of presumed vascular origin (WMH) are frequent in cerebral magnetic resonance imaging of older people. They are promoted by vascular risk factors, especially hypertension, and are...
7.
Jokisch M, Schramm S, Weimar C, Moebus S, Gronewold J, Dragano N, et al.
Front Behav Neurosci
. 2022 Nov;
16:988621.
PMID: 36386784
Background: Depression might be an independent risk factor for cognitive decline, a prodromal dementia symptom or a reaction to cognitive/functional impairment. Objective: To investigate the association between (1) depressive symptoms...
8.
Fleischer M, Szepanowski F, Tovar M, Herchert K, Dinse H, Schweda A, et al.
Neurol Ther
. 2022 Aug;
11(4):1637-1657.
PMID: 36028604
Introduction: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can affect multiple organs. Reports of persistent or newly emergent symptoms, including those related to the nervous system, have increased over...
9.
Gronewold J, Jokisch M, Schramm S, Himpfen H, Ginster T, Tenhagen I, et al.
J Hypertens
. 2022 Aug;
40(12):2413-2422.
PMID: 35983864
Objectives: White matter hyperintensities (WMH) of presumed vascular origin are frequent in cerebral MRI of older people. They represent a sign of small vessel disease, are promoted by arterial hypertension,...
10.
Schramm S, Jokisch M, Jockel K, Herring A, Keyvani K
Alzheimers Res Ther
. 2021 Dec;
13(1):202.
PMID: 34930454
Background: Kallikrein-8 (KLK8) might be an early blood-biomarker of Alzheimer's disease (AD). We examined whether blood KLK8 is elevated in persons with amnestic mild cognitive impairment (aMCI) which is a...